Phorm Corp (PHORF) 0.0100 $PHORF Phorm Corporation

New Post Public Reply Private Reply Replies (0) Message Board

Jun 22, 2016 at 8:06 PM

Phorm Corp (PHORF) 0.0100 $PHORF

Phorm Corporation Limited Announces Issue of US$500,000 of Convertible Loan Notes
Marketwired - Wed Mar 16, 2:00AM CDT
Phorm (AIM: PHRM),

Phorm Corporation Limited - Subscription Update, Short Term Loan Agreement, New Subscription and Conversion of Existing Unsecured Term Loans
Marketwired - Mon Feb 01, 12:00PM CST
Phorm (AIM: PHRM), a leading advertising-technology company and first party data platform provider, announces that, further to its announcement of 18 January 2016 regarding a subscription to raise approximately US$1 million (gross) (the "Subscription"

, the sole US based institutional subscriber (the "Subscriber"

has to date failed to transfer the requisite funds to settle the transaction as required pursuant to the terms of a legally binding subscription agreement entered into between the Company and the Subscriber (the "Subscription Agreement"

.

Phorm Awarded TRUSTe Certified Privacy Seal
Marketwired - Thu Jan 21, 1:00AM CST
Phorm Corporation Limited (AIM: PHRM)

Phorm Corporation Limited Announces Subscription to Raise Approximately US$1 Million Gross and Operational Update
Marketwired - Mon Jan 18, 1:00AM CST
Phorm Corporation Limited (AIM: PHRM)

Phorm Corporation Limited Announces Repricing of Options
Marketwired - Mon Dec 07, 1:00AM CST
Phorm Corporation Limited (AIM: PHRM)

Phorm Corporation Limited: Phorm Enables Hover Rate With Insomnis Media
Marketwired - Thu Dec 03, 5:24AM CST
Phorm (AIM: PHRM)

Phorm Corporation Limited Announces Adoption of New Share Option Plan and Grant of Options
Marketwired - Tue Dec 01, 1:00AM CST
Phorm Corporation Limited

Phorm Corporation Limited Announces Equity Fundraising of GBP 2.1m (Approximately US$3.2m) Gross
Marketwired - Fri Nov 06, 1:00AM CST
Phorm Corporation Limited (AIM: PHRM)

Phorm Corporation Limited Announces Partnering Agreement With INSOMNIS Media Limited
Marketwired - Wed Oct 28, 2:00AM CDT
Phorm Corporation Limited (AIM: PHRM)

Phorm Corporation Limited: Agreement With Causemo, Inc.
Marketwired - Tue Oct 20, 1:00AM CDT
Phorm Corporation Limited (AIM: PHRM)

Phorm Hires Chief Revenue Officer
Marketwired - Tue Oct 13, 1:00AM CDT
Phorm (AIM: PHRM)

Phorm Corporation Limited: Agreement With Boston Globe Media Group
Marketwired - Fri Oct 09, 1:00AM CDT
Phorm (AIM: PHRM)

Phorm Corporation Limited: Interim Results for the Six Months Ended 30 June 2015
Marketwired - Wed Sep 30, 10:25AM CDT
Phorm (AIM: PHRM), an advertising-technology company, announces its unaudited interim results for the six months ended 30 June 2015.

Phorm Corporation Limited: Result of AGM
Marketwired - Fri Aug 28, 9:26AM CDT
Phorm (AIM: PHRM)

Phorm Corporation Limited: Equity Fundraising of Approximately GBP 3.2 Million
Marketwired - Fri Aug 07, 5:31AM CDT
Phorm Corporation Limited (AIM: PHRM)

Phorm Corporation Limited: Update re Board Changes
Marketwired - Wed Jul 29, 2:37AM CDT
Phorm Corporation Limited (AIM: PHRM)

Phorm Corporation Limited Announces Loan Agreement and Extension of Convertible Loan Notes
Marketwired - Tue Jul 28, 1:00AM CDT
Phorm Corporation Limited (LSE: PHRM) (AIM: PHRM)

Phorm Corporation Limited: Board and Management Changes
Marketwired - Wed Jul 15, 5:51AM CDT
Phorm (AIM: PHRM), a leading internet personalisation technology company, announces certain changes to the board of directors of Phorm (the "Board"

and senior management of the Company, to position it to take advantage of the opportunities which have recently opened up in the US market. As part of the changes, Kent Ertugrul, Chief Executive Officer and Executive Chairman, based in Singapore, and Andy Croxson, Chief Financial Officer, based in London, have stepped down from their respective roles effective immediately. Mr Ertugrul and Mr Croxson will be pursuing their other business interests but remain strongly supportive of the Company's continued progress. The Company is currently in the process of appointing Mr Timothy Todd Smith to the Board as Chief Executive Officer.

Phorm Corporation Limited: Operational Update
Marketwired - Fri Jul 03, 1:00AM CDT
Phorm Corporation Limited ("Phorm" or the "Company)

Bigger Capital Applauds Appointment of Michael Alkin to Phorm's Board
PR Newswire - Thu Jul 02, 9:28AM CDT
The Bigger Capital Fund, LP, Bachelier, LLC and the Bigger Family (together, "Bigger Capital" or "we"

, a significant shareholder of Phorm Corporation Limited (AIM: PHRM) ("Phorm" or the "Company"

, owning 20,713,435 ordinary shares, representing approximately 2.5% of the outstanding shares, today announced that it has issued an open letter to Phorm's shareholders and Board of Directors. The full text of the letter is included below:

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

New Concierge Pediatric Care at Weill Cornell Launches

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Postal Service Defends New Rule Amid Speculation

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

TrailBlazer Magazine Snags a Tribune for In-House Design

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

MMRO Achieves URAC AI Accreditation, Ensures Compliance

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...